Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Epic Bio
Epic Bio Presents New Data Highlighting Potential of EPI-321 for FSHD and Epigenetic Editing Platform Leadership at ASGCT Annual Meeting
April 23, 2024
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
April 10, 2024
From
Epic Bio
Via
GlobeNewswire
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
April 09, 2024
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Participate in a Fireside Chat at the Cantor Virtual Muscular Dystrophy Symposium
April 01, 2024
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
March 13, 2024
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present at the Upcoming CRISPR2.0 Conference
November 21, 2023
From
Epic Bio
Via
GlobeNewswire
FDA Grants Orphan Drug Designation to EPI-321, Epic Bio's Novel Genetic Medicine Candidate for Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
November 16, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Participate in Upcoming Investor Conference
November 07, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio Reports New Data on Hypercompact Cas Proteins Optimized for Broad Therapeutic Applicability
October 26, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present at the Upcoming Annual European Society of Gene and Cell Therapy
October 19, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio Announces the Appointment of Weston Miller, M.D., as Chief Medical Officer
October 17, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
October 05, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
September 28, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
September 19, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
September 14, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio Named a “Fierce 15” Company by Fierce Biotech
August 28, 2023
From
Epic Bio
Via
Business Wire
Epic Bio Presents New Data on Epigenetic Editing Platform at CRISPR Frontiers Conference
August 17, 2023
From
Epic Bio
Via
Business Wire
Epic Bio Presents Compelling Preclinical Data Supporting Clinical Initiation of EPI-321 for FSHD
June 16, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Participate in a Fireside Chat at the Stifel Genetic Medicines Day 2023
May 23, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio Presents Preclinical Data on EPI-321 for Facioscapulohumeral Muscular Dystrophy at ASGCT 26th Annual Meeting
May 19, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Present Preclinical Data at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
May 04, 2023
From
Epic Bio
Via
GlobeNewswire
SOLVE FSHD Invests in Epic Bio to Advance Potentially Curative Therapy
April 18, 2023
From
Epic Bio
Via
GlobeNewswire
Epic Bio to Participate in the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days
March 29, 2023
From
Epic Bio
Via
Business Wire
In Pivotal Demonstration, Epic Bio Accomplishes Persistent Gene Activation with Single Administration
March 14, 2023
From
Epic Bio
Via
Business Wire
Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences
March 06, 2023
From
Epic Bio
Via
Business Wire
Amber Salzman, Ph.D., CEO of Epic Bio, Recognized by Endpoints News as One of the Most Influential Women in Biopharma R&D
December 07, 2022
From
Epic Bio
Via
Business Wire
Epic Bio to Participate in the BMO Virtual Spotlight Series
November 15, 2022
From
Epic Bio
Via
Business Wire
Epic Bio Presents First Data Supporting Persistent and Tunable Gene Activation Using Transient Delivery
October 31, 2022
From
Epic Bio
Via
Business Wire
Epic Bio to Participate in the 6th International Conference on Epigenetics and Bioengineering
October 25, 2022
From
Epic Bio
Via
Business Wire
Epic Bio Presents Proprietary Gene Expression Modulation System (GEMS) Demonstrating Precise Engineering of DUX4 Gene in Facioscapulohumeral Muscular Dystrophy
October 13, 2022
From
Epic Bio
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.